Global Inhalation Anesthesia Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Inhalation Anesthesia Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Inhalation anesthetics are used to induce and maintain general anesthesia while performing surgical procedures. Inhalation anesthetic agents are administered through masks or tracheal tubes. These agents get perfused into blood though alveoli and transported to central nervous system where these induce anesthesia.
Inhalation Anesthesia report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Inhalation Anesthesia market is projected to reach US$ 1397.5 million in 2034, increasing from US$ 1128.8 million in 2022, with the CAGR of 3.1% during the period of 2024 to 2034. Demand from Induction and Maintenance are the major drivers for the industry.
Inhalation anesthesia has an advantage over other intravenous agents and is considered safer by surgeons. Rising adoption of these drugs in major markets such as U.S., Europe, and Japan is expected to drive revenue growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Inhalation Anesthesia market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AbbVie Inc.
Baxter
Piramal Enterprises Limited
Halocarbon Products Corporation
Hikma Pharmaceuticals PLC
Lunan Pharmaceutical Group Co.Ltd.
Jiangsu Hengrui Medicine Co. Ltd.
Fresenius Kabi Ag
Segment by Type
Sevoflurane
Desflurane
Isoflurane
Induction
Maintenance
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Inhalation Anesthesia market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Inhalation Anesthesia, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Inhalation Anesthesia industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Inhalation Anesthesia in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Inhalation Anesthesia introduction, etc. Inhalation Anesthesia Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Inhalation Anesthesia market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Inhalation Anesthesia report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Inhalation Anesthesia market is projected to reach US$ 1397.5 million in 2034, increasing from US$ 1128.8 million in 2022, with the CAGR of 3.1% during the period of 2024 to 2034. Demand from Induction and Maintenance are the major drivers for the industry.
Inhalation anesthesia has an advantage over other intravenous agents and is considered safer by surgeons. Rising adoption of these drugs in major markets such as U.S., Europe, and Japan is expected to drive revenue growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Inhalation Anesthesia market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AbbVie Inc.
Baxter
Piramal Enterprises Limited
Halocarbon Products Corporation
Hikma Pharmaceuticals PLC
Lunan Pharmaceutical Group Co.Ltd.
Jiangsu Hengrui Medicine Co. Ltd.
Fresenius Kabi Ag
Segment by Type
Sevoflurane
Desflurane
Isoflurane
Segment by Application
Induction
Maintenance
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Inhalation Anesthesia market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Inhalation Anesthesia, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Inhalation Anesthesia industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Inhalation Anesthesia in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Inhalation Anesthesia introduction, etc. Inhalation Anesthesia Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Inhalation Anesthesia market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices